FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells

Cancer Letters

Volumn 254, Issue 2, 2007, Pages 288-297

  Shen, Yan ^a   Cai, Minxia ^a   Xia, Weiliang ^a   Liu, Junwei ^a   Zhang, Qiyi ^a   Xie, Haiyang ^a   Wang, Chen ^a   Wang, Xiaohui ^a   Zheng, Shusen ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

Apoptosis; FTY720; Pancreatic carcinoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; CASPASE 9; FINGOLIMOD; PROTEIN BCL 2; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; FLOW CYTOMETRY; FUNGUS; HUMAN; HUMAN CELL; ISARIA SINCLAIRII; METASTASIS; ORGAN TRANSPLANTATION; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING; WOUND CLOSURE;

ADENOCARCINOMA; APOPTOSIS; ASCOMYCOTA; CELL DIVISION; CELL LINE, TUMOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PANCREATIC NEOPLASMS; PROPYLENE GLYCOLS; SPHINGOSINE; WOUND HEALING;

ISARIA SINCLAIRII;

EID: 34547408777     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.03.013     Document Type: Article

References (27)

1. Suzuki S. FTY720: mechanisms of action and its effect on organ transplantation. Transplant. Proc. 31 (1999) 2779-2782
2. Wang J.D., Takahara S., and Nonomura N. Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation. Prostate 40 (1999) 50-55
3. Jernal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. CA Cancer J. Clin. 54 (2004) 8-29
4. Adachi K., Kohara T., Nakano N., et al. Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1, 3-propane-diols: discovery of a novel immunosuppressant, FTY720. Bioorg. Med. Chem. Lett. 5 (1995) 853-856
5. Nagahara Y., Enosawa S., Ikekita M., et al. Evidence that FTY720 induces T cell apoptosis in vivo. Immunopharmacology 48 (2000) 75-85
6. Azuma H., Takahara S., Ichimaru N., et al. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res. 62 (2002) 1410-1419
7. Azuma H., Takahara S., Horie S., et al. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment. J. Urol. 169 (2003) 2372-2377
8. Sonoda Y., Yamamoto D., Sakurai S., et al. FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells. Biochem. Biophys. Res. Commun. 281 (2001) 282-288
9. Kim J.B., Stein R., and O'Hare M.J. Three-dimensional in vitro tissue culture models of breast cancer - a review. Breast Cancer Res. Treat. 85 (2004) 281-291
10. Burbanch B.J., Ji Y., and Rapraeger A.C. Syndecan-1 ectodomain regulates matrix-dependent signaling in human breast carcinoma cells. Exp. Cell Res. 300 (2004) 234-247
11. Liu B., Staren E., Iwamura T., et al. Effects of taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SUIT-2. World J. Gastroenterol. 7 (2001) 143-148
12. Wolf W.C., Evans D.M., Chao L., et al. A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness. Am. J. Pathol. 159 5 (2001) 1797-1805
13. Bergenfeldt M., and Albertsson M. Current state of adjuvant therapy in resected pancreatic adenocarcinoma. Acta Oncol. 45 (2006) 124-135
14. Lidestahl A., Permert J., Linder S., et al. Efficacy of systemic therapy in advanced pancreatic carcinoma. Acta Oncol. 45 (2006) 136-143
15. Tanaka T., Takahara S., Hatori M., et al. A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine. Cancer Lett. 181 (2002) 165-171
16. Matsuoka Y., Nagahara Y., Ikekita M., et al. A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells. Br. J. Pharmacol. 138 (2003) 1303-1312
17. Matsyda S., Minowa A., Suzuki S., et al. Differential activation of c-Jun NH2-terminal and p38 pathways during FTY720-induced apoptosis of lymphocyte that is suppressed by the extracellular signal-regulated kinase pathway. J. Immunol. 162 (1999) 3321
18. Lee T.K., Man K., Ho J.W., et al. FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin. Cancer Res. 11 23 (2005) 8458-8466
19. Schmid G., Guba M., Papyan A., et al. FTY720 inhibits tumor growth and angiogenesis. Transplant. Proc. 37 (2005) 110-111
20. Zhou C., Ling M.T., Kin-Wah Lee T., et al. FTY720, a fungas metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase. Cancer Lett. 233 (2006) 36-47
21. Azuma H., Takahara S., Ichimaru N., et al. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res. 62 (2002) 1410-1419
22. Lee T.K., Man K., Ho J.K., et al. Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target. Carcinogenesis 26 (2005) 681-687
23. Asnaghi L., Calastretti A., Bevilacqua A., et al. Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt. Oncogene 23 (2004) 5781-5791
24. Jin Y.P., Fishbein M.C., Said J.W., et al. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum. Immunol. 65 (2004) 291-302
25. Dong M., Zhou J.P., Zhang H., et al. Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer. World J. Gastroenterol. 11 (2005) 2744-2747
26. Lee Y.S., Nakajima H., Tsuruga M., et al. Elimination of Cell-cycle Regulators during Caspase-3-dependent Apoptosis Caused by an Immunosuppressant, FTY720. Biosci. Biotech. Biochem. 67 (2003) 467-474
27. Nakajima H., Lee Y.S., Matsuda T., et al. Different mechanisms for membrane and nuclear damages in apoptosis induced by an immunosuppressant, FTY720. Mol. Cell 14 (2002) 332-338